| 1 |
34818963 | Targeting acute myeloid leukemia through multimodal immunotherapeutic approaches. | 2022 Apr |
1 |
| 2 |
32630417 | Pulmonary Involvement in a Mouse Model of Sjögren's Syndrome Induced by STING Activation. | 2020 Jun 25 |
1 |
| 3 |
29505322 | Activation of Stimulator of Interferon Genes (STING) and Sjögren Syndrome. | 2018 Jul |
1 |
| 4 |
23710296 | Refractoriness of interferon-beta signaling through NOD1 pathway in mouse respiratory epithelial cells using the anticancer xanthone compound. | 2013 May 26 |
1 |
| 5 |
23027866 | 5,6-Dimethylxanthenone-4-acetic acid (DMXAA) activates stimulator of interferon gene (STING)-dependent innate immune pathways and is regulated by mitochondrial membrane potential. | 2012 Nov 16 |
1 |
| 6 |
21819972 | Activation of mitogen-activated protein kinases by 5,6-dimethylxanthenone-4-acetic acid (DMXAA) plays an important role in macrophage stimulation. | 2011 Nov 1 |
1 |
| 7 |
16783963 | Inhibition of DMXAA-induced tumor necrosis factor production in murine splenocyte cultures by NF-kappaB inhibitors. | 2006 |
1 |
| 8 |
16357188 | Activation of tumor-associated macrophages by the vascular disrupting agent 5,6-dimethylxanthenone-4-acetic acid induces an effective CD8+ T-cell-mediated antitumor immune response in murine models of lung cancer and mesothelioma. | 2005 Dec 15 |
1 |